CAVAGNA, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 9.310
AS - Asia 5.410
EU - Europa 4.102
SA - Sud America 941
Continente sconosciuto - Info sul continente non disponibili 485
AF - Africa 302
OC - Oceania 9
Totale 20.559
Nazione #
US - Stati Uniti d'America 8.882
CN - Cina 2.049
SG - Singapore 1.407
IE - Irlanda 916
BR - Brasile 706
HK - Hong Kong 655
IT - Italia 613
DE - Germania 540
RU - Federazione Russa 505
VN - Vietnam 501
FI - Finlandia 395
FR - Francia 270
UA - Ucraina 226
GB - Regno Unito 217
BD - Bangladesh 207
CA - Canada 193
ZA - Sudafrica 178
IN - India 165
AT - Austria 109
SE - Svezia 101
AR - Argentina 67
IQ - Iraq 64
MX - Messico 50
CO - Colombia 46
JP - Giappone 45
EC - Ecuador 42
ES - Italia 41
TR - Turchia 36
CR - Costa Rica 33
ID - Indonesia 32
MA - Marocco 30
NL - Olanda 30
IL - Israele 29
PK - Pakistan 28
SA - Arabia Saudita 28
PL - Polonia 27
VE - Venezuela 27
GT - Guatemala 26
MY - Malesia 24
BE - Belgio 23
SV - El Salvador 23
UZ - Uzbekistan 21
HN - Honduras 20
LT - Lituania 16
TN - Tunisia 15
TT - Trinidad e Tobago 15
BO - Bolivia 14
JM - Giamaica 14
KE - Kenya 14
PY - Paraguay 14
CW - ???statistics.table.value.countryCode.CW??? 13
EG - Egitto 13
JO - Giordania 13
PH - Filippine 13
AZ - Azerbaigian 12
CL - Cile 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
NI - Nicaragua 11
PR - Porto Rico 11
GP - Guadalupe 10
DZ - Algeria 9
NP - Nepal 9
SC - Seychelles 9
AU - Australia 8
PE - Perù 8
ET - Etiopia 7
AL - Albania 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
KG - Kirghizistan 6
KR - Corea 6
OM - Oman 6
PT - Portogallo 6
EE - Estonia 5
KZ - Kazakistan 5
NG - Nigeria 5
RS - Serbia 5
UY - Uruguay 5
AM - Armenia 4
BY - Bielorussia 4
LB - Libano 4
MK - Macedonia 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BS - Bahamas 3
CG - Congo 3
CH - Svizzera 3
DK - Danimarca 3
KH - Cambogia 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
Totale 20.042
Città #
San Jose 1.020
Dublin 900
Chandler 770
Singapore 727
Ashburn 713
Hong Kong 646
Dallas 601
Council Bluffs 599
Beijing 411
Jacksonville 329
Nanjing 289
Boardman 258
Los Angeles 246
Helsinki 208
Munich 203
Lauterbourg 198
Ho Chi Minh City 182
Princeton 171
Johannesburg 155
New York 155
Lawrence 140
Wilmington 128
Hanoi 124
Nanchang 116
Redondo Beach 113
Santa Clara 113
Shanghai 112
Medford 107
Shenyang 89
Milan 86
Vienna 86
Changsha 84
Hebei 80
São Paulo 80
Buffalo 79
Jiaxing 78
Moscow 78
Tianjin 73
Columbus 62
Ann Arbor 58
Pavia 58
Hangzhou 57
Orem 55
Chicago 53
Brooklyn 49
Rome 48
London 47
Phoenix 46
Turku 45
Atlanta 42
Nuremberg 42
Falkenstein 41
North Bergen 41
Toronto 40
Tokyo 38
Montreal 37
Frankfurt am Main 33
San Francisco 33
Seattle 33
Washington 33
Boston 31
Woodbridge 31
Denver 30
The Dalles 30
Houston 29
Naples 29
Norwalk 29
San José 27
Baghdad 25
Pune 25
Da Nang 23
Stockholm 23
Chennai 22
Rio de Janeiro 22
Brasília 21
Brussels 21
San Salvador 21
Warsaw 21
Fairfield 20
Haiphong 20
Manchester 19
Tashkent 19
Guangzhou 18
Mexico City 18
Turin 18
Hyderabad 17
Poplar 16
Riyadh 16
Charlotte 15
Guatemala City 15
Zhengzhou 15
Belo Horizonte 14
Philadelphia 14
Quito 14
Amsterdam 13
Dhaka 13
Las Vegas 13
Nairobi 13
New Delhi 13
Porto Alegre 13
Totale 12.344
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 284
A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. 199
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 176
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 166
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 166
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 166
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET 154
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 153
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 152
A case of adult onset Still's disease treated with infliximab - Reply 148
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 145
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 145
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 144
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 143
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 142
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 140
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 140
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 138
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 137
"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity 135
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjogren syndrome 135
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 134
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 132
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 131
Spondiliti e spondilodisciti batteriche. 129
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 129
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 127
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 127
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 125
Association between anti-dsDNA titre increase and thymoma relapse 124
The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: A Retrospective population-based study in Southern Italy 124
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 123
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 123
Interessamento cutaneo nella dermatomiosite 121
Performance of classification criteria for gout in early and established disease 119
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 118
Biosimilars: Lights and shadows in rheumatology 118
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 118
Adhesive capsulitis after COVID-19 vaccine injection: a peculiar case treated with combined bursa distention and glenohumeral capsular hydrodilatation 117
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 117
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 116
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 116
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 116
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 115
Defining anti-synthetase syndrome: a systematic literature review 115
Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study 114
Study for updated gout classification criteria: Identification of features to classify gout 113
Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial 113
Influence of MUC5B gene on antisynthetase syndrome 112
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 112
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET 111
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 110
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 109
Respiratory failure due to concomitant interstitial lung disease and diaphragmatic involvement in a patient with anti-MDA5 dermatomyositis: a case report 108
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 108
Myo-regressor Deep Informed Neural NetwOrk (Myo-DINO) for fast MR parameters mapping in neuromuscular disorders 107
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 107
One year in review 2018: idiopathic inflammatory myopathies 107
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 106
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 106
Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. 104
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project 103
One year in review 2019: idiopathic inflammatory myopathies 103
Therapy of necrotizing arteritis | [La terapia delle vasculiti necrotizzanti] 102
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. 102
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 102
Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies 102
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 102
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 102
A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria 101
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 101
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography 100
Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review 99
Cardiovascular involvement in rheumatoid arthritis [L'interessamento cardiaco nell'artrite reumatoide] 99
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 99
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 99
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 99
Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease 99
Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis 98
La poliangioite microscopica. 98
Pain in arthritis 98
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 98
Clinical spectrum of anti-Jo-1-associated disease 98
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 98
Neutrophil Extracellular Traps in the Autoimmunity Context 97
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 97
Idiopathic inflammatory myopathies: one year in review 2021 97
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 96
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: Long-term real-life data from the Lorhen registry 95
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 95
Anti-neutrophil cytoplasmic antibodies (ANCA) 94
Genetics and novel aspects of therapies in systemic lupus erythematosus 94
Methotrexate and rheumatoid arthritis associated interstitial lung disease 94
Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated 94
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: The effect of rofecoxib withdrawal 93
Therapeutic options in Anti-Jo1 antisynthetase syndrome with interstitial lung disease. 92
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis. 91
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. 91
Polyarthrite rhumatoïde associée à un trait bêta-thalassémique : aspect clinique, sérologique et immunogénétique 91
Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. 91
Totale 11.793
Categoria #
all - tutte 97.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 0 0 0 17 14 22 45 35 9 105 403
2022/20232.427 270 193 32 194 195 194 6 149 1.076 10 56 52
2023/20241.062 110 196 38 61 67 269 38 61 7 78 37 100
2024/20253.250 75 209 128 101 65 159 257 217 719 143 367 810
2025/20267.766 557 466 920 843 804 276 1.246 439 703 639 514 359
2026/20272.938 208 640 530 1.089 471 0 0 0 0 0 0 0
Totale 20.559